Chargement en cours...
Pharmacokinetic and technical comparison of Sandostatin(® )LAR(® )and other formulations of long-acting octreotide
BACKGROUND: Sandostatin(® )LAR(® )(Novartis Pharma AG) is a long-acting repeatable formulation of the somatostatin analogue octreotide, the safety and efficacy of which has been established through 15 years of clinical experience. Recently, other formulations of octreotide using polymer poly(lactic-...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3212992/ https://ncbi.nlm.nih.gov/pubmed/21906300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-4-344 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|